NCT03166345CompletedNot Applicable
Use of Platelet Rich Plasma (PRP) for Improving Thin Endometrium For IVF Women
Conditions
Interventions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Ibn Sina Hospital
- Enrollment
- 150
- Locations
- 4
- Primary Endpoint
- Mean Diameter of endometrial thickness
Study Overview
Brief Summary
Platelets rich plasma is simple source of growth factors and cytokines that can regulate endometrial growth for subgroup of thin endometrium women. It is an autologous source of this enhancing factors; therefore, there os no risk of using it within the same participant.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Other
- Masking
- Single (Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to 40 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •women with thin endometrium
Exclusion Criteria
- •serum positive hepatitis B and C women
Arms & Interventions
No intervention
No Intervention
The control arm.
PRP injection into Uterine Cavity
Experimental
PRP injection into Uterine Cavity For Treatment of Thin Endometrium
Intervention: Treatment of Thin Endometrium (Other)
CSF (colony stimulating factor)
Experimental
CSF for Treatment of Thin Endometrium
Intervention: Treatment of Thin Endometrium (Other)
Outcomes
Primary Outcomes
Mean Diameter of endometrial thickness
Time Frame: 2 days
How the endometrium would respond after 2 days of PRP
Secondary Outcomes
- Clinical pregnancy rate(4 weeks or beyond after embryo Transfer)
Investigators
Muhammad Fawzy
IVF Lab Director
Ibn Sina Hospital
Study Sites (4)
Loading locations...
Similar Trials
Unknown
Not Applicable
Platelet-Rich Protein and the EndometriumInfertilityNCT02973555Hadassah Medical Organization50
Withdrawn
Phase 1
Platelet Rich Plasma Uterine InfusionInfertilityEndometriosisNCT06621342University of Kansas Medical Center
Recruiting
Not Applicable
Platelet Rich Plasma for improving reduced ovarian function, ovarian failure and thinning of uterine liningCTRI/2018/04/013006Dr Manjula Anagani
Completed
Phase 3
Intraarticular Injections of Platelet-rich Plasma in Pain's Treatment of the Osteoarthritic KneeKnee OsteoarthritisNCT02448407Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud52
Unknown
Not Applicable
PRP Prevents Recurrence of Intrauterine AdhesionsIntrauterine AdhesionNCT03629132Yanhong Deng60